Tuberculosis control and managed competition in Colombia

被引:23
|
作者
Arbelaez, MP
Gaviria, MB
Franco, A
Restrepo, R
Hincapié, D
Blas, E
机构
[1] Univ Antioquia, Fac Nacl Salud Publ, Medellin, Colombia
[2] WHO, UNICEF, UNDP, World Bank,Special Programme Res Training Trop Di, CH-1211 Geneva, Switzerland
关键词
tuberculosis; managed competition; health sector reform; public goods; Colombia;
D O I
10.1002/hpm.775
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Law 100 introduced the Health Sector Reform in Colombia, a model of managed competition. This article addresses the effects of this model in terms of output and outcomes of TB control. Trends in main TB control indicators were analysed using secondary data sources, and 25 interviews were done with key informants from public and private insurers and provider institutions, and from the health directorate level. We found a deterioration in the performance of TB control: a decreasing number of BCG vaccine doses applied, a reduction in case finding and contacts identification, low cure rates and an increasing loss of follow up, which mainly affects poor people. Fragmentation occurred as the atomization and discontinuity of the technical processes took place, there was a lack of coordination, as well as a breakdown between individual and collective interventions, and the health information system began to disintegrate. The introduction of the Managed Competition (MC) in Colombia appeared to have adverse effects on TB control due to the dominance of the economic rationality in the health system and the weak state stewardship. Our recommendations are to restructure the reform's public health component, strengthen the technical capacity in public health of the state, mainly at the local and departmental levels, and to improve the health information system by reorienting its objectives to public health goals. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:S25 / S43
页数:19
相关论文
共 50 条
  • [1] Managed competition in Colombia: convergence of public and private insurance and delivery
    Castano, Ramon
    Prada, Sergio I.
    Maldonado, Norman
    Soto, Victoria
    HEALTH ECONOMICS POLICY AND LAW, 2024,
  • [2] To Control Costs Expand Managed Care and Managed Competition
    Enthoven, Alain
    Fuchs, Victor R.
    Shortell, Stephen M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (21): : 2075 - 2076
  • [3] Barriers of access to care in a managed competition model: lessons from Colombia
    Vargas, Ingrid
    Luisa Vazquez, Maria
    Susana Mogollon-Perez, Amparo
    Unger, Jean-Pierre
    BMC HEALTH SERVICES RESEARCH, 2010, 10
  • [4] Barriers of access to care in a managed competition model: lessons from Colombia
    Ingrid Vargas
    María Luisa Vázquez
    Amparo Susana Mogollón-Pérez
    Jean-Pierre Unger
    BMC Health Services Research, 10
  • [5] Understanding Consumer Preferences in the Context of Managed Competition Evidence from a Choice Experiment in Colombia
    Trujillo, Antonio
    Ruiz, Fernando
    Bridges, John
    Amaya, Jeannette
    Buttorff, Christine
    Quiroga, Angelica
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2012, 10 (02) : 99 - 111
  • [6] MANAGED COMPETITION
    PETERSDORF, RG
    ACADEMIC MEDICINE, 1993, 68 (04) : 265 - 265
  • [7] Managed Competition
    Prestwich, Brian
    HEALTH AFFAIRS, 2018, 37 (12) : 2100 - 2100
  • [8] MANAGED COMPETITION
    IGLEHART, JK
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (16): : 1208 - 1212
  • [9] THE CHALLENGE OF MANAGED CARE AND MANAGED COMPETITION
    SUNSHINE, JH
    EVENS, RG
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 162 (04) : 767 - 771
  • [10] MarketWatch - Can managed care and competition control Medicare costs?
    Gold, M
    HEALTH AFFAIRS, 2003, 22 (03) : W176 - W188